课题基金 / 基金详情

DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY

DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
二炔抗生素及其 DNA 裂解化学
批准号:
2700458
负责人:
CRAIG ARTHUR TOWNSEND
金额:
$24.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-05-10 至 2000-04-30

项目摘要

项目成果

CRAIG ARTHUR TOWNSEND的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Calicheamicin gamma1I (CLM), the neocarzinostatin chromophore, esperamicin A1, dynemicin, kedarcidin, c-1027 and maduropeptin are members of the structurally unprecedented and growing family of diynene antitumor antibiotics. Reductive activation by thiols and/or simple thermal rearrangement generates diradical species by an electrocyclization process that is characteristic of this class. When bound in the minor groove of DNA these radicals initiate helix cleavage by hydrogen abstraction from one or both strands. The resulting DNA radicals react with molecular oxygen and fragmentation ensues. While single-strand breaks are typically the major cleavage event observed, CLM is both notably sequence-selective and very largely a double-strand cutter. Using a diverse array of experiments outlined in this renewal proposal we seek to understand the origins of these properties and how CLM can be used as a probe of protein/nucleic acid structure and in the design of useful tools in molecular biology. The presumed lethality of DNA damage, the induction of apoptosis and the demonstrated cytotoxicity and cell cycle effects of these compounds have animated hope that, through preferential uptake or selective delivery to cancer cells, effective therapies might be possible. Clinical trials testing the latter principle are underway. Investigation of the low kinetic isotope effects associated with CLM- induced hydrogen abstraction from DNA and the apparent absence of isotope-induced branching will be completed. Whether these two events occur in a simultaneous or stepwise manner will be distinguished. The unusual behavior of A-tracts will be examined for kinetic acceleration as a function of minor groove narrowing. The efficiencies of hydrogen abstraction will be monitored and the distribution of cuts in the cleavage cascade will be evaluated as a function of temperature. The interaction of CLM with supercoiled plasmid DNA will be investigated as a function of inserted A/T-rich segments causing varying degrees of curvature. Extensive experiments are planned with nucleosomes to study the occurrence of "hot spots" to understand whether CLM cleavage is associated with physical location in the nucleosome or features of particular DNA sequences. Automated methods will be used to evaluate large amounts of data generated in mixed sequence nucleosomes. A degradation product of CLM having essentially no sequence selectivity but retaining double-strand cutting properties will be linked to homeodomains to achieve specific binding for high efficiency cleavage of DNA. Success in this effort will be evaluated in tests with DNA sequences already in hand and will lay the groundwork for eventual experiments to be undertaken for gene identification e.g. in Drosophila. Finally, CLM reaction with transfer-, ribosomal- and messenger-RNA will be investigated. In eukaryotic cells, RNA is a more accessible target than DNA. These experiments will monitor the susceptibility of RNA to reaction with CLM and particularly with rRNA in the ribosome for comparison to nucleosomes and chromatin.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/bi00168a029
发表时间: 1994
期刊: Biochemistry
影响因子: 2.9
作者: [Mah,SC, Townsend,CA, Tullius,TD]
通讯作者: Tullius,TD
Biosynthesis of Beta Lactam Antibiotics
  • 批准号:
    10295587
  • 项目类别:
  • 资助金额:
    $56.09万
  • 财政年份:
    2016
  • 负责人:
    CRAIG ARTHUR TOWNSEND
  • 依托单位:
Biosynthesis of Beta Lactam Antibiotics
  • 批准号:
    10406371
  • 项目类别:
  • 资助金额:
    $62.97万
  • 财政年份:
    2016
  • 负责人:
    CRAIG ARTHUR TOWNSEND
  • 依托单位:
Biosynthesis of Beta Lactam Antibiotics
  • 批准号:
    10601097
  • 项目类别:
  • 资助金额:
    $61.94万
  • 财政年份:
    2016
  • 负责人:
    CRAIG ARTHUR TOWNSEND
  • 依托单位:
400 MHZ NMR SPECTROMETER FOR SHARED USE: CHEMISTRY
  • 批准号:
    6973212
  • 项目类别:
  • 资助金额:
    $36.37万
  • 财政年份:
    2004
  • 负责人:
    CRAIG ARTHUR TOWNSEND
  • 依托单位:
国内基金
海外基金
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    程子译
  • 依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
  • 批准号:
    2026JJ81091
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘亮
  • 依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
  • 批准号:
    2026JJ50010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    应站明
  • 依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
  • 批准号:
    JCZRLH202600588
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: